Effect of early chemotherapy intensification with BEACOPP in high-tisk, interim-PET positive, advanced-stage Hodgkin lymphoma on overall treatment outcome of ABVD

被引：0
|
作者：
Fiore, F.
Patti, K.
Viviani, S.
Rossi, A.
Di Raimondo, F.
Cantonetti, M.
Feldman, T.
Biggi, A.
Barrington, S.
Gallamini, A.
机构：
[1] S Croce Mem Hosp, Dept Hematol, Cuneo, Italy
[2] V Cervello Hosp, Dept Hematol, Palermo, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[4] Osped Riuniti Bergamo, Dept Hematol, Bergamo, Italy
[5] Univ Catania, Dept Hematol, Catania, Italy
[6] Univ Roma Tor Vergata, Dept Hematol, Rome, Italy
[7] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[8] S Croce Gen Hosp, Dept Nucl Med, Cuneo, Italy
[9] Kings Coll London, PET Imaging Ctr St Thomas, Div Imaging, London WC2R 2LS, England
[10] S Croce Gen Hosp, Dept Hematol, Cuneo, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8006
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
    Gallamini, Andrea
    Patti, Caterina
    Viviani, Simonetta
    Rossi, Andrea
    Fiore, Francesca
    Di Raimondo, Francesco
    Cantonetti, Maria
    Stelitano, Caterina
    Feldman, Tatyana
    Gavarotti, Paolo
    Sorasio, Roberto
    Mule, Antonino
    Leone, Monica
    Rambaldi, Alessandro
    Biggi, Alberto
    Barrington, Sally
    Fallanca, Federico
    Ficola, Umberto
    Chauvie, Stephane
    Gianni, Alessandro Massimo
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (05) : 551 - 560
  • [2] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE, ADVANCED-STAGE, ABVD-TREATED HODGKIN LYMPHOMA PATIENTS
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Stelitano, C.
    Feldman, T.
    Gavarotti, P.
    Sorasio, R.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    HAEMATOLOGICA, 2010, 95 : S22 - S22
  • [3] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE ADVANCED-STAGE HODGKIN LYMPHOMA, IMPROVES THE OVERALL TREATMENT OUTCOME OF ABVD: A GITIL MULTICENTER CLINICAL STUDY
    Gallamini, A.
    Fiore, F.
    Sorasio, R.
    Rambaldi, A.
    Patti, C.
    Stelitano, C.
    Viviani, S.
    Di Raimondo, F.
    Feldman, T.
    Biggi, A.
    Rossi, A.
    Mistretta, A.
    Bonfante, V.
    Chiarenza, A.
    Cantonetti, M.
    Gavarotti, P.
    Tarella, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 204 - 204
  • [4] Early treatment intensification with escalated BEACOPP after interim PET in advanced Hodgkin Lymphoma patients not responding to ABVD therapy
    Malkowski, B.
    Danielewicz, I.
    Lesniewski-Kmak, K.
    Zalewska, M.
    Zaucha, R.
    Szefer, J.
    Zaucha, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S476 - S476
  • [5] Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
    Gallamini, A.
    Kostakoglu, L.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1045 - 1047
  • [6] Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305)
    Kusumoto, Shigeru
    Munakata, Wataru
    Machida, Ryunosuke
    Terauchi, Takashi
    Onaya, Hiroaki
    Oguchi, Masahiko
    Iida, Shinsuke
    Nosaka, Kisato
    Suzuki, Yasuhiro
    Harada, Yasuhiko
    Miyazaki, Kana
    Maruta, Masaki
    Fukuhara, Noriko
    Toubai, Tomomi
    Kubota, Nobuko
    Ohmachi, Ken
    Saito, Toko
    Rai, Shinya
    Mizuno, Ishikazu
    Fukuhara, Suguru
    Takeuchi, Mai
    Tateishi, Ukihide
    Maruyama, Dai
    Tsukasaki, Kunihiro
    Nagai, Hirokazu
    CANCER SCIENCE, 2024, 115 (10) : 3384 - 3393
  • [7] EARLY CHEMOTHERAPY INTENSIFICATION WITH ESCALATED BEACOPP IN ADVANCED-STAGE HODGKIN LYMPHOMA WITH A POSITIVE INTERIM PET-CT AFTER 2 ABVD CYCLES: LONG-TERM RESULTS OF THE GITIL/FIL HD 0607 TRIAL
    Gallamini, A.
    Rossi, A.
    Patti, K.
    Picardi, M.
    Romano, A.
    Cantonetti, M.
    La Nasa, G.
    Trentin, L.
    Bolis, S.
    Rapezzi, D.
    Viviani, S.
    Gianni, A. M.
    Zoli, V.
    Gottardi, D.
    Tarella, C.
    Gavarotti, P.
    Corradini, P.
    Cimminiello, M.
    Schiavotto, C.
    Parvis, G.
    Zanotti, R.
    Gini, G.
    Ferreri, A. J.
    Viero, P.
    Miglino, M.
    Billio, A.
    Avigdor, A.
    Prosperini, G.
    Bergesio, F.
    Pavoni, C.
    Rambaldi, A.
    HAEMATOLOGICA, 2017, 102 : 145 - 146
  • [8] Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP
    Adams, Hugo J. A.
    Kwee, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) : 758 - 760
  • [9] Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma
    Kobe, Carsten
    Goergen, Helen
    Baues, Christian
    Kuhnert, Georg
    Voltin, Conrad-Amadeus
    Zijlstra, Josee
    Hoekstra, Otto
    Mettler, Jasmin
    Drzezga, Alexander
    Engert, Andreas
    Borchmann, Peter
    Dietlein, Markus
    BLOOD, 2018, 132 (21) : 2273 - 2279
  • [10] Early Intensification Treatment Approach in Advanced-stage Hodgkin Lymphoma
    Borchmann, Peter
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (01) : 65 - +
12345